Consolidated Balance Sheets - USD ($) $ in Thousands	Dec. 31, 2023	Dec. 31, 2022
Assets
Cash and cash equivalents	$ 76,200	$ 97,401
Accounts receivable, net of allowance for credit losses	136,259	136,142
Financing receivables, net of allowance for credit losses	127,154	129,384
Variable consideration receivables, net of allowance for credit losses	64,338	44,024
Inventories	31,584	31,534
Prepaid expenses	12,345	12,343
Film assets, net of accumulated amortization	6,786	5,277
Property, plant and equipment, net of accumulated depreciation	243,299	252,896
Investment in equity securities	0	1,035
Other assets	20,879	15,665
Deferred income tax assets, net of valuation allowance	7,988	9,900
Goodwill	52,815	52,815
Other intangible assets, net of accumulated amortization	35,022	32,738
Total assets	814,669	821,154
Liabilities
Accounts payable	26,386	25,237
Accrued and other liabilities	111,013	117,286
Deferred revenue	67,105	70,940
Revolving credit facility borrowings, net of unamortized debt issuance costs	22,924	36,111
Convertible notes and other borrowings, net of unamortized discounts and debt issuance costs	229,131	226,912
Deferred income tax liabilities	12,521	14,900
Total liabilities	469,080	491,386
Commitments, contingencies and guarantees (see Notes 15 and 16)
Non-controlling interests
Non-controlling interests	658	722
Shareholders' equity
Capital stock common shares - no par value. Authorized - unlimited number. 53,260,276 issued and outstanding (December 31, 2022 - 54,148,614 issued and outstanding)	389,048	376,715
Other equity	185,087	185,678
Statutory surplus reserve	3,932	3,932
Accumulated deficit	(292,845)	(293,124)
Accumulated other comprehensive loss	(12,081)	(9,846)
Total shareholders' equity attributable to common shareholders	273,141	263,355
Non-controlling interests	71,790	65,691
Total shareholders' equity	344,931	329,046
Total liabilities and shareholders' equity	$ 814,669	$ 821,154